Skip To Main Content
Abbey Barnard Giustini on Muck Rack

Abbey Barnard Giustini

As seen in: Wiley Online Library, Medscape
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Abbey Barnard

Contact Abbey Barnard, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Editorial: Understanding the Role of the Alpha-1 Pi*MZ Genotype in the Development of Hepatocellular Carcinoma for Patients With ACLD

|
By Abbey Barnard Giustini, J. Llovet, Kaitlyn Carlson
| Wiley Online Library Verified
Handling Editor: Daniel Huang K.Carlson and A. B.Giustini, “Editorial: Understanding the Role of the Alpha-1 Pi*MZ Genotype in the Development of Hepatocellular Carcinoma for Patients With ACLD,” Alimentary Pharmacology & Therapeutics (2026): 1–2, https://doi.org/10.1111/apt.70548. Advanced chronic liver disease (ACLD) is the strongest risk factor for the development of HCC, the third leading cause of cancer-death worldwide [1].
Open in Who Shared Issue with article?

Modalities for Screening and Imaging Diagnosis of HCC

|
By Abbey Barnard Giustini, George N. Ioannou, Claude B. Sirlin, Rohit Loomba
| Medscape Verified
close Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out Cancel Abstract and Introduction Abstract Background: Hepatocellular carcinoma (HCC) incidence and mortality continue to rise worldwide. Society guidelines recommend HCC screening for patients with chronic hepatitis B (CHB) or cirrhosis.
Open in Who Shared Issue with article?

Review article: Available modalities for screening and imaging diagnosis of hepatocellular carcinoma-Current gaps and challenges

|
By George N. Ioannou, Claude B. Sirlin, Rohit Loomba, Abbey Barnard Giustini
| Wiley Online Library Verified
REVIEW ARTICLE The Handling Editor for this article was Professor Gideon Hirschfield, and this review was accepted for publication after full peer-review Summary Background Hepatocellular carcinoma (HCC) incidence and mortality continue to rise worldwide. Society guidelines recommend HCC screening for patients with chronic hepatitis B (CHB) or cirrhosis. Unfortunately, HCC screening rates remain relatively low, and the performance characteristics of current screening modalities are suboptimal.
Open in Who Shared Issue with article?
See all 3 articles